HIV drugs in pregnancy linked to slightly increased birth defect risk

04/29/2014 | HealthDay News

Prenatal use of antiretroviral drugs, such as zidovudine and efavirenz, among HIV-positive women was associated with a slightly greater likelihood of birth defects in offspring, according to a French study in the journal PLOS Medicine. However, the health risks linked to the use of these medications are far outweighed by the benefits of averting mother-to-child HIV transmission, the researchers said.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC